Compare LOB & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | LOB | HTFL |
|---|---|---|
| Founded | 2008 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.2B |
| IPO Year | 2014 | 2025 |
| Metric | LOB | HTFL |
|---|---|---|
| Price | $39.48 | $47.82 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $43.00 | $38.20 |
| AVG Volume (30 Days) | 168.1K | ★ 2.3M |
| Earning Date | 04-22-2026 | 05-14-2026 |
| Dividend Yield | ★ 0.32% | N/A |
| EPS Growth | 31.95 | ★ 82.37 |
| EPS | ★ 1.35 | N/A |
| Revenue | N/A | ★ $176,034,000.00 |
| Revenue This Year | $35.52 | $27.66 |
| Revenue Next Year | $16.03 | $23.55 |
| P/E Ratio | $29.34 | ★ N/A |
| Revenue Growth | N/A | ★ 39.92 |
| 52 Week Low | $29.36 | $20.13 |
| 52 Week High | $44.53 | $51.78 |
| Indicator | LOB | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 38.99 | 66.84 |
| Support Level | $35.70 | $47.13 |
| Resistance Level | $42.56 | $51.19 |
| Average True Range (ATR) | 0.95 | 2.33 |
| MACD | -0.14 | -0.42 |
| Stochastic Oscillator | 19.60 | 40.45 |
Live Oak Bancshares Inc operates as the bank holding company for the Live Oak Banking Company. The company specializes in lending and deposit-related services to small businesses nationwide. The company identifies and extends lending to credit-worthy borrowers both within specific industries, also called verticals, through expertise within those industries, and more broadly to select borrowers outside of those industries. A portion of the loans originated by the Bank are partially guaranteed by the Small Business Administration under the 7(a) Loan Program and the U.S. Department of Agriculture Rural Energy for America Program, Water and Environmental Program, Business and Industry and Community Facilities loan programs.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.